Precigen, Inc. cash flow to debt ratio of -89.36% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

Precigen, Inc.'s free cash flow has decreased 17.03% from $-76.76M last year to $-89.83M, signaling decreasing performance

Precigen, Inc.'s debt to equity ratio is 1.18, which means that the company's assets are unhealthy financed, signaling financial risk.

Precigen, Inc.'s debt has increased relative to shareholder equity from 0.14 last year to 1.18 today, signaling weakened financials

Precigen, Inc. has negative EBITDA, making leverage ratio unreliable

Precigen, Inc.'s interest coverage ratio of 2.85 indicates that earnings with margin can cover interest payments on company debt

Precigen, Inc.'s profit margin was -3.22K% last year and is 15.55% this year, signaling increasing performance

Precigen, Inc.'s short-term assets of $115.23M exceed its short-term liabilities of $37.31M

Precigen, Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

Precigen, Inc.'s return on equity of 57.93%, is higher than 15.00%, indicating good performance

Precigen, Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

Precigen, Inc. had positive net income in only 1 out of 5 years, indicating unstable earnings

Precigen, Inc. has negative free cash flow, indicating the company is burning cash rather than generating it

Precigen, Inc. has negative free cash flow, indicating cash burn

Precigen, Inc.'s yearly earnings has decreased 98.55% since last year from $-126.23M to $-250.64M, signaling decreasing performance

Precigen, Inc.'s yearly revenue has increased 146.73% since last year from $3.92M to $9.68M, signaling increasing performance

ROIC 18.28% (Source: FMP key-metrics). At or above the 10% threshold. Score: 2 of 2. The company is generating returns above the upper end of the typical US weighted-average cost of capital range under this definition of invested capital.

Precigen, Inc.'s 3-year revenue CAGR of -28.87% is negative, indicating declining revenue over the past 3 years

Precigen, Inc. had revenue growth in only 2 out of 5 years, indicating inconsistent revenue performance

Precigen, Inc. had positive ROE in only 1 out of 5 years, indicating inconsistent returns on equity

Precigen, Inc. has insufficient data to evaluate this check.

Precigen, Inc. has an earnings yield of 1.52%, which is below the 4.00% threshold, indicating the stock may be expensive relative to its earnings

Precigen, Inc. is overvalued relative to its fair value price of 0.00 based on Base EBITDA Valuation model

Precigen, Inc. has negative or missing EBITDA, making EV/EBITDA ratio unreliable

Precigen, Inc. has insufficient data to evaluate this check.

Precigen, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Precigen, Inc. has a price-to-book ratio of 19.11x, which exceeds the 5.00x threshold, indicating the stock may be overvalued relative to its book value

Precigen, Inc. has a price-to-sales ratio of 10.20x, which exceeds the 8.00x threshold, indicating the stock may be overvalued relative to its revenue